New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant Mycobacterium tuberculosis.
Article in Journal of Medical Microbiology (July 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Journal of Medical Microbiology (July 2024)
Article in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (July 2024)
Article in Chinese Journal of Clinical Infectious Diseases (June 2023)